COPD共病症的治療：全身抗發炎藥物的市場機會

COPD共病症的治療：全身抗發炎藥物的市場機會 是由出版商Decision Resources, Inc.在2008年03月所出版的。 這份英文市場調查報告書包含42 Pages 價格從美金2250起跳。

簡介

目錄

Abstract

Introduction

Research data on COPD increasingly point to systemic infl ammation as the cause of many of the severe comorbidities associated with the disease. However, agents under study for COPD continue to focus only on the local infl ammation caused by the disease. Signifi cant opportunity exists for agents that can reduce the infl ammation both in the lungs and throughout the system. Given that inhaler drugs will not be displaced as the primary treatment for the disease, is there a drug on the market for another indication that will address the systemic comorbidities associated with COPD? Should any existing therapies be able to show clear clinical benefi t on systemic infl ammation, such an agent would gain a useful competitive edge in the COPD market.

Get the Answers You Need to Shape Your Strategy

• COPD is a progressive infl ammatory disease affecting the respiratory tract and the lungs. What comorbidities are associated with COPD? What roles do local and systemic infl ammation play in this disease? What is the status of research on the connection between systemic infl ammation and pulmonary function?
• Researchers are beginning to investigate the potential of systemic agents in the treatment of COPD. What are some of the most promising drug classes being studied? Will these agents have an effect on the localized symptoms and the severe comorbidities?
• See the appendix in this report for a discussion on the current treatments for localized COPD. What are the most effective treatments? What new therapies need to be considered?

Scope

• The role of inflammation in the comorbidities in COPD: therapies are needed to address the multiple facets of the disease; established agent for another indication may be aimed at COPD.
• Risk factors: cigarette smoking; particulate dust; impaired lung development; age; nutritional and socioeconomic factors.
• Comorbidities: chronic cardiovascular diseases; osteoporosis; type 2 diabetes; cachexia.
• Treatments most likely to address systemic infl ammation: TNF-α inhibitors; PPAR-gamma agonists; statins; PDE-5 inhibitors.

Table of Contents

• Executive Summary
  • Strategic Considerations
  • Stakeholder Implications
• Introduction
• Understanding the Mechanisms of COPD
  • Risk Factors for COPD
  • Pathophysiology of COPD
    • Small Airway Disease
    • Emphysema
  • Role of Systemic Infl ammation in COPD
• Comorbidities Associated with COPD Caused by Systemic Infl ammation
  • Cardiovascular Complications: Atherosclerosis and Pulmonary Arterial Hypertension
    • Atherosclerosis
    • Pulmonary Arterial Hypertension
  • Osteoporosis
  • Type 2 Diabetes
  • Cachexia
• Drug Classes with Possible Use in Treating the Systemic and Localized Infl ammation of COPD
  • TNF-α Inhibitors
  • PPAR-Gamma Agonists
  • Statins
  • PDE Inhibitors
• Assessing the Unanswered Questions About Treating Systemic Infl ammation in COPD
• Appendix:Current Treatments for Localized COPD
  • Short-Acting Beta2 Agonists
  • Long-Acting Beta2 Agonists
  • Muscarinic Antagonists
  • Inhaled Corticosteroids
  • Beta2 Agonist/Muscarinic Antagonist Combinations
  • Long-Acting Beta2 Agonist/Inhaled Corticosteroid Combinations
  • Methylxanthines

Tables:

• 1. Sales of Leading Agents to Treat COPD, 2006
• 2. Risk Factors Linked to COPD
• 3. Infl ammatory Molecules Involved in COPD
• 4. Existing and Emerging TNF-α Inhibitors, 2008
• 5. Existing and Emerging PPAR-Gamma Agonists, 2008
• 6. Approved Statins, 2008
• 7. Approved and Emerging PDE 4 and 5 Inhibitors, 2008

Figures:

• 1. Prevalent Cases of COPD in the United States, Europe, and Japan, 2006 and 2011
• 2. Comorbidities Associated with COPD

相關商品

Decision Resources, Inc.發行的製藥相關市場調查報告書

大型醫藥品經營者的非專利藥品部門的成功可能性

Will Big Pharma Find Success in Generics?

價格 : US $ 4600

出版日期 : 2011年11月

呼吸系統疾病策略的趨勢

Industry Outlook: Trends in Respiratory Disease Strategies

價格 : US $ 4600

出版日期 : 2011年11月

兒童克隆氏症治療的現在的治療方法·未滿足需求·機會

Special Report: Current Treatments, Unmet Needs, and Opportunities in Treating Pediatric Crohn's Disease

價格 : US $ 9200

出版日期 : 2011年11月

Email Alert(Email 通知) - 最新市場調查報告書

GII 將每天定期更新最新市場調查報書資訊，選擇您有興趣的市場分類，我們將用Email的方式讓您收到最新訊息!